Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA Still Waiting For Cures Money, Woodcock Says

Executive Summary

When asked about Cures-related hiring, CDER Director says to her knowledge, no funding has been received yet.

You may also be interested in...



Gottlieb Showing Capitol Hill Skills With Funding Success

US FDA gains $94m in new funding for international mail facilities, a priority for the commissioner, along with an increase in non-user fee dollars for agency operations.

US FDA May Create Immunology, Neuroscience Centers Of Excellence

Commissioner Gottlieb says new centers would follow template of Oncology Center of Excellence.

US FDA Hiring Initiative Aims To Get Scientific Staff More Involved In Recruitment

Commissioner Gottlieb's pilot program also creates dedicated recruitment staff that will work to fill prescription drug user fee-related openings, streamline the hiring process and improve employee retention.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS120498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel